BALTIMORE (KFSN) -- Overactive bladder is a common problem, especially as we age, but it's something that most of us probably don't want to talk about. Now, a cosmetic procedure that is much better ...

OnabotulinumtoxinA, approved by the US Food and Drug Administration (FDA) in 2013 to treat overactive bladder (OAB), may be an appropriate second-line treatment option for select patients with OAB, ...

Urinary distress inventory scores improved with either treatment over 6 months. Both onabotulinimtoxinA (BTX) and midurethral sling (MUS) show efficacy over 6 months in treating women with mixed ...

When her patient insisted on receiving Botox bladder injections in the operating room (OR), Anne Pelletier Cameron, MD, asked her why. The patient acknowledged her last time receiving the injections ...